Haemacure Corp (HAEUF/HAEUF.PK) Penny Stock Summary:

Haemacure Corporation, a specialty bio-therapeutics company, engages in the development and commercialization of human biological adhesives, hemostats, and therapeutic proteins primarily in the United States and Canada. Its lead product candidate includes Hemaseel HMN, a fibrin sealant, which is a biological tissue glue with sealing, haemostatic, and adhesive properties for wound healing. The company plans to conduct pivotal Phase II/Phase III clinical trials on Hemaseel HMN. The company?s product in pre-clinical stage comprises Hemaseel Thrombin, a haemostatic agent that consists of human thrombin, a component of fibrin sealant. It has a collaboration agreement with Angiotech Pharmaceuticals Inc. for the development of company?s fibrin and thrombin technologies. Haemacure Corporation was founded in 1991 and is headquartered in Montreal, Canada.

Pink Sheets: Archieved Financial News About Haemacure Corp

You can still leave a comment about Haemacure Corp HAEUF/HAEUF.PK